Loading…
Employees: 2,400
Size Varex Imaging (VREX) is a United States Health Care company (Medical Specialties) with a market value of $783M, the 2410th largest of 3,117 United States companies the cockpit tracks. Shares closed at $12.41 on 6 Nov 2026.
Performance Over six months the shares fell 9.9%, against -9.1% for the median peer and -1.1% for the United States market (cap-weighted) — 11th highest of 21 in its peer set.
Growth Revenue grew 5.3% over the last twelve months (peer median +13.0%); the operating margin is 8.3% (peer median 11.2%).
Valuation It trades at 20.3× forward earnings against a peer median of 22.4× (7th cheapest of 15).
Capital Return on invested capital runs 1.4 points below its cost of capital (8.5% WACC).
Short interest Short interest is 3.8% of the free float (15 Oct 2026).
Next results Next results expected around 24 Nov 2026 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $865M | $845M | $811M | $893M | $859M |
| Revenue growth | — | +4% | -9% | +4% | — |
| Gross profit | $297M | $290M | $257M | $290M | $284M |
| EBITDA | $99.5M | $93.3M | $63.2M | $110M | $124M |
| Net income | $22.1M | -$70.3M | -$48.8M | $48.2M | $30.3M |
| Free cash flow | -$20.2M | $17.6M | $18.1M | $87.7M | -$4.40M |
| Capital expenditure | $31.5M | $22.9M | $26.9M | $20.7M | $21.3M |
| Total debt | $379M | $402M | $477M | $470M | $437M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | VREX | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +15.2% | -3.6% | 3rd highest of 21 |
| 6-month return | -9.9% | -9.1% | 11th highest of 21 |
| Distance from 52-week high | -14.8% | -28.7% | 5th highest of 21 |
| Revenue growth (TTM) | +5.3% | +13.0% | 7th lowest of 21 |
| Operating margin | 8.3% | 11.2% | 10th lowest of 21 |
| Forward P/E | 20.3× | 22.4× | 7th cheapest of 15 |
| ROIC minus cost of capital | -1.4 pp | +0.3 pp | 10th lowest of 21 |
| EV / EBITDA | 10.8× | 13.3× | 3rd cheapest of 7 |
| Net debt / EBITDA | 2.8× | -1.0× | 3rd most indebted of 8 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Varex Imaging VREX | United States | $783M | -10% | +5% | 8% | 20.3× | n/a | n/a |
| Shanghai INT Medical Instruments 1501.HK | Hong Kong | $784M | -25% | +35% | 21% | 17.8× | -2.1% | +23.5% |
| BMC Medical 301367.SZ | China | $780M | -13% | +37% | 17% | 19.8× | 0.1% | +15.6% |
| Standard Engineering Technology SETL.NS | India | $796M | +164% | +26% | 13% | n/a | n/a | n/a |
| Cofoe Medical Technology 1187.HK | Hong Kong | $798M | -27% | +40% | 10% | 12.5× | -8.0% | +6.6% |
| Allmed Medical Products 002950.SZ | China | $798M | -39% | +14% | 8% | n/a | n/a | n/a |
| InMode INMD | United States | $767M | -5% | -7% | 18% | 10.1× | -10.5% | +12.4% |
| Shanghai Aladdin Biochemical Technology 688179.SS | China | $806M | -25% | +39% | 26% | 30.0× | 21.1% | +24.2% |
| Cytek Biosciences CTKB | United States | $758M | +26% | +5% | -22% | n/a | n/a | n/a |
| Doctorglasses Chain 300622.SZ | China | $757M | -10% | +6% | 14% | 24.5× | -2.4% | +15.7% |
| Maccura Biotechnology 300463.SZ | China | $814M | -14% | -1% | -4% | 164.7× | 9.2% | -10.2% |
| Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZ | China | $750M | +177% | -14% | 3% | n/a | 33.5% | -0.6% |
| Shenzhen Lifotronic Technology 688389.SS | China | $749M | -11% | +14% | 13% | 32.4× | 13.5% | +13.3% |
| Advanced Medical Solutions AMS.L | United Kingdom | $824M | +14% | +6% | 12% | 20.7× | 19.6% | +21.4% |
| Hangzhou Biotest Biotech 688767.SS | China | $824M | +5% | -4% | 3% | 34.7× | n/a | n/a |
| Jiang Xi Sanxin Medtec 300453.SZ | China | $741M | -5% | +12% | 18% | 16.1× | -2.1% | +11.8% |
| OrthoPediatrics KIDS | United States | $829M | +78% | +16% | -8% | n/a | n/a | n/a |
| Beijing Aerospace Changfeng 600855.SS | China | $832M | -35% | -10% | -19% | n/a | n/a | n/a |
| QuidelOrtho QDEL | United States | $734M | -1% | -5% | -2% | 12.0× | n/a | n/a |
| Shenzhen Sunnypol Optoelectornics 002876.SZ | China | $728M | -8% | +29% | 5% | 41.8× | 11.1% | +14.2% |
| SWS Hemodialysis Care 688410.SS | China | $723M | -12% | +31% | 19% | 24.1× | 16.7% | +25.9% |